Photo
26.05.2021 • Whitepaper

Analytical Testing of Cosmetics

Cosmetic products often consist of a long list of ingredients, including potentially harmful substances. The identification and precise quantification of these substances is crucial to ensure the quality and safety of cosmetics.

Photo
25.05.2021 • Topics • Chemistry

Sustainable Synthesis of Biochemicals

When Circa was founded in 2006, the company’s aim was to convert non-food cellulose into high-performance, renewable chemicals, at scale — extracting value from waste biomass and addressing a gap in the market for better, more sustainable materials.

Photo
25.05.2021 • Topics • Chemistry

Is the Beauty Industry Sending the Wrong Message?

As gender and diversity, as well as the body positivity movement, become more and more prevalent among young consumers, beauty companies are finding that they are going to have to re-define how products are advertised if they want to stay relevant.

Photo
04.05.2021 • Topics • Strategy

The Role of Clean Hydrogen for a Climate Neutral Industry

Europe wants to become the world’s first climate-neutral continent by 2050 and decouple its economic growth from the consumption of natural resources – this is what the members of the European Union committed to in the so-called Green Deal in December 2019.

Photo
16.04.2021 • Topics • Innovation

Vaccine Filling at the Highest Level

Recent studies show that contract manufacturers for the pharmaceutical industry, so-called CDMOs (contract development and manufacturing organizations), have so far been little involved in the production of vaccines. This is changing with the outbreak of the Covid-19 pandemic.

1914 more articles

Top-Feature

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.